Author: AWA

Attracting Capital – Guiding the Growth Journey

In a series of programs initiated by AWA Denmark, the focus will be on what potential growth entrepreneurs should

Read more...

MedTrace receives $30 million investment fuelling US expansion and new business area

AWA’s client MedTrace Pharma A/S has received nearly $30 million from Swiss-based Swisscanto Invest and Danish investors ATP and

Read more...

CellaVision acquires exclusive rights to novel microscopy technology

AWA’s client CellaVision has signed an agreement to acquire the exclusive rights to a patent portfolio on Fourier Ptychographic

Read more...

EPO releases Patent Index 2020: Applications stable despite pandemic, healthcare innovation soars and the US tops geographic origin of applications outside of Europe

The European Patent Office (EPO) released its Patent Index 2020 this week. Despite the coronavirus pandemic, filings remained stable

Read more...

Guide: EU Trademarks after Brexit

EU trademarks will no longer be protected in the UK after Brexit. What will happen to your EUTM depends

Read more...

Denmark champions patents as fundamental to preventing climate change

Danish Minister for Industry, Business and Financial Affairs Simon Kollerup stated that protecting the intellectual property rights of innovative

Read more...

Brexit may stall Germany’s ratification of the UPCA

The German Justice Ministry expressed earlier this month that the government will not ratify the Unified Patent Court Agreement

Read more...

The invention causing a storm at music festivals this year – Lapee

When people think of music festivals they think of bright lights, loud music, alcohol and crowds of people coming

Read more...
blood

ExThera Medical: Drug resistance

Based in Martinez, California (US), ExThera Medical (ExThera) has developed a state-of-the-art device that filters harmful bacteria and viruses

Read more...
Affibody molecule

Affibody molecule: A molecule that can detect breast cancer

Every month is breast cancer awareness month for Swedish Biopharmaceutical R&D company Affibody, which has developed unique molecular technologies

Read more...

Mobile Sliding Menu